Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

NCT07224750 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07224750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07224750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
June 21, 2024
Completion date
June 18, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, colorectal cancer screening, esophageal squamous cell carcinoma (escc), gastric cancer (gc), hepatocellular carcinoma (hcc), pancreatic ductal adenocarcinoma (pdac)